Reference health

Transcriptomic profiling of a multiethnic pediatric NAFLD cohort reveals genes and pathways associated with disease

https://doi.org/10.1002/hep4.1940
CiteStamped reference-health badge
40/40 checkable references clean · checked 2026-07-22

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

9 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 40 checked references that resolve
resolves10.1038/s42255-020-0183-z
Childhood obesity and the associated rise in cardiometabolic complications
resolves10.1002/hep.28431
Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes
resolves10.1542/peds.2006-1212
Prevalence of Fatty Liver in Children and Adolescents
resolves10.1136/gut.2008.171280
The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years
resolves10.1016/j.cld.2015.10.003
The Progression and Natural History of Pediatric Nonalcoholic Fatty Liver Disease
resolves10.1038/s41575-019-0145-7
From NASH to HCC: current concepts and future challenges
resolves10.1038/nrgastro.2017.109
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
resolves10.1002/hep.23119
Advances in Pediatric Nonalcoholic Fatty Liver Disease†
resolves10.1016/j.dld.2012.04.009
Genetic predisposition and increasing dietary fructose exposure: The perfect storm for fatty liver disease in Hispanics in the U.S.
resolves10.3748/wjg.v20.i23.7347
Pediatric fatty liver disease: Role of ethnicity and genetics
resolves10.1002/hep.27695
Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n‐3 and n‐6 polyunsaturated fatty acids
resolves10.1002/hep.20701
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
resolves10.1002/hep.24127
Nonalcoholic Fatty Liver Disease (NAFLD) Activity Score and the Histopathologic Diagnosis in NAFLD: Distinct Clinicopathologic Meanings §Δ
resolves10.1093/bioinformatics/btu170
Trimmomatic: a flexible trimmer for Illumina sequence data
resolves10.1093/bioinformatics/bts635
STAR: ultrafast universal RNA-seq aligner
resolves10.1021/acs.jproteome.5b00354
Analysis of the Human Adult Urinary Metabolome Variations with Age, Body Mass Index, and Gender by Implementing a Comprehensive Workflow for Univariate and OPLS Statistical Analyses
resolves10.1093/nar/gkn282
KEGG Atlas mapping for global analysis of metabolic pathways
resolves10.1053/j.gastro.2015.05.039
High Prevalence of Nonalcoholic Fatty Liver Disease in Adolescents Undergoing Bariatric Surgery
resolves10.1093/bioinformatics/btw313
Complex heatmaps reveal patterns and correlations in multidimensional genomic data
resolves10.2337/db07-0932
High Visceral and Low Abdominal Subcutaneous Fat Stores in the Obese Adolescent
resolves10.1016/j.cmet.2015.06.010
Calcium Homeostasis and Organelle Function in the Pathogenesis of Obesity and Diabetes
resolves10.1016/j.tem.2019.02.005
Calcium Signaling As a Therapeutic Target for Liver Steatosis
resolves10.1016/j.cell.2021.04.015
Mechanisms and disease consequences of nonalcoholic fatty liver disease
resolves10.1002/hep4.1479
Pathogenesis of Nonalcoholic Steatohepatitis: An Overview
resolves10.1053/j.gastro.2019.05.002
Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis
resolves10.1002/hep.26746
IL-17 Signaling Accelerates the Progression of Nonalcoholic Fatty Liver Disease in Mice
resolves10.1210/clinem/dgaa792
Relationship of IGF-1 and IGF-Binding Proteins to Disease Severity and Glycemia in Nonalcoholic Fatty Liver Disease
resolves10.1210/jc.2002-021315
Generation of Anti-Insulin-Like Growth Factor-Binding Protein-Related Protein 1 (IGFBP-rP1/MAC25) Monoclonal Antibodies and Immunoassay: Quantification of IGFBP-rP1 in Human Serum and Distribution in Human Fluids and Tissues
resolves10.1016/j.jhep.2019.06.023
Prevalence of prediabetes and diabetes in children and adolescents with biopsy-proven non-alcoholic fatty liver disease
resolves10.1126/science.abg7292
Caloric restriction in humans reveals immunometabolic regulators of health span
resolves10.1002/hep.29367
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
resolves10.1016/j.cgh.2014.04.014
Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies
resolves10.1053/j.gastro.2019.11.312
MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease
resolves10.1002/hep.29085
Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysis
resolves10.3892/mmr.2020.11249
Expression of Notch family is altered in non‑alcoholic fatty liver disease
resolves10.1056/NEJMcibr1815636
Notch and Nonalcoholic Fatty Liver and Fibrosis
resolves10.1002/hep.26997
Insulin-Like Growth Factor 2 mRNA-Binding Protein 1 (IGF2BP1) Is an Important Protumorigenic Factor in Hepatocellular Carcinoma
resolves10.1038/onc.2014.35
miR-625 suppresses tumour migration and invasion by targeting IGF2BP1 in hepatocellular carcinoma
resolves10.1210/er.2001-0033
Cellular Actions of the Insulin-Like Growth Factor Binding Proteins
resolves10.1002/hep.23133
Nonalcoholic Steatohepatitis in Children
The 9 references without a DOI — listed, not checked
no DOI — not checkedThe prevalence of non‐alcoholic fatty liver disease in children and adolescents: a systematic review and meta‐analysis
no DOI — not checkedTranscriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis
no DOI — not checkedGene expression predicts histological severity and reveals distinct molecular profiles of nonalcoholic fatty liver disease
no DOI — not checkedModerated estimation of fold change and dispersion for RNA‐seq data with DESeq2
no DOI — not checkedGSVA: gene set variation analysis for microarray and RNA‐seq data
no DOI — not checkedDietary cholesterol promotes steatohepatitis related hepatocellular carcinoma through dysregulated metabolism and calcium signaling
no DOI — not checkedPrevalence of prediabetes and type 2 diabetes in children with nonalcoholic fatty liver disease
no DOI — not checkedLiver‐spleen axis, insulin‐like growth factor‐(IGF)‐I axis and fat mass in overweight/obese females
no DOI — not checkedPhysiological disturbance in fatty liver energy metabolism converges on IGFBP2 abundance and regulation in mice and men
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1002/hep4.1940"><img src="https://citestamp.com/citestamped/10.1002/hep4.1940/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1002/hep4.1940/badge.svg)](https://citestamp.com/citestamped/10.1002/hep4.1940)